Albert Ferrer is a founding partner of Invivo Capital Partners (also known as Invivo Partners). See contact routes.
Albert Ferrer is a founding partner of Invivo Capital Partners (also known as Invivo Partners), a Barcelona-based venture capital firm that invests exclusively in early-stage healthcare and life sciences companies, with a distinctive thesis focused on technology transfer from research centers to advanced therapies and synthetic biology. The firm targets pre-seed, seed, and Series A stages, typically deploying €0.5–€4 million per initial investment, with follow-ons up to €10 million for companies 1–2 years from first-in-human trials. Notable portfolio companies include Sanifit (acquired by Vifor), Versantis (acquired by Genfit), Peptomyc, Arthex, and Glycardial Diagnostics, reflecting Ferrer’s 20-year focus on high-growth, science-driven life sciences ventures.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Barcelona.
Investors like Albert Ferrer · Full investor directory · Investor access · Company funding database